Recently, it was reported that therapy-resistant or drug-tolerant cells, which are represented by a high mesenchymal state, depend on the glutathione peroxidase 4 (GPX4) pathway to evade ferroptosis, suggesting that ferroptosis induction represents an anticancer strategy for these therapy resistant cancer cells [10,11]. This evidence concerns the gene GPX4 and cancer.